How much funding has ViAn Therapeutics raised?

ViAn Therapeutics has raised $275K in total funding, most recently a seed round.

Who are ViAn Therapeutics's investors?

ViAn Therapeutics's investors include IndieBio, Sand Hill Angels, Ulu Ventures.

When was ViAn Therapeutics founded?

ViAn Therapeutics was founded in 2023.

Where is ViAn Therapeutics headquartered?

ViAn Therapeutics is headquartered in San Francisco, California, United States.

What industry is ViAn Therapeutics in?

ViAn Therapeutics operates in Biotech, Healthcare.

How many employees does ViAn Therapeutics have?

ViAn Therapeutics has 1-10 employees.

ViAn Therapeutics

Protecting sight with a simple eye drop.

San Francisco, United States · Founded 2023 · $275K raised

Biotech

Healthcare

Headquarters: San Francisco, California
Employees: 1–10
Founded: 2023
Business Model: B2B

Website: viantx.com
Total Funding: $275K
Last Round: $275K SeedOct 2023
Rounds: 1

About

VIAN Therapeutics is a virtual pharma startup developing a topical antiangiogenic eye drop (VIAN-001) to treat retinal vascular diseases including AMD and diabetic macular edema. Their lead compound inhibits VEGF and Ang-2 to prevent pathological angiogenesis and vascular permeability. The company is backed by IndieBio and founded by Dr. Juan Pablo Robles.

Summary

ViAn Therapeutics is a Biotech company based in San Francisco, United States, founded in 2023. It has raised $275K in total across 1 round, most recently a $275K Seed round in Oct 2023. Investors include IndieBio, Sand Hill Angels and Ulu Ventures.